Infectious Diseases Pharmacy Specialist; PGY1 RPC- @UnivHealthSA. PGY1 / PGY2 ID- @OSUWexMed. PharmD- @UTexasPharmacy.
San Antonio, TX
Joined March 2016
- Tweets614
- Following1.5K
- Followers957
- Likes3K
Pinned Tweet
Leveraging Pharmacy Residents during COVID-19 Pandemic. At @OSUWexMed pharmacy residents provided innovative ways to care for COVID-19 patients. View our experiences across our numerous pharmacy residency programs. @lisaGmo @osu_pharmacy
academic.oup.com/ajhp/advanc…
Lindsey Groff, PharmD, BCIDP retweeted
🆕💥🟢Economic Outcomes of Dalbavancin versus Standard Therapy in Staphylococcus aureus Bacteremia in the DOTS Randomized Clinical Trial #idxposts academic.oup.com/cid/article…
Lindsey Groff, PharmD, BCIDP retweeted
⭐️Shout out to our OPAT pharmacists!⭐️
Systematic review of 10 studies w/ RX in OPAT:
⬇️ readmissions
⬇️ prescribing errors
🔺high degree of bias
🔺various definitions for outcomes
🎯RX in OPAT can impact patient care and💲despite inconsistent outcomes
academic.oup.com/jac/article…
Lindsey Groff, PharmD, BCIDP retweeted
This infographic is a fantastic summary of the beta-lactamase inhibitors reviewed in the new #Breakpoints episode "Beta-lactamase inhibitors: Scientifically elegant, just complex." Use this infographic as a reference, and be sure to share!
#infographic #newepisode
Lindsey Groff, PharmD, BCIDP retweeted
BREAKING: San Antonio Spurs' Victor Wembanyama has signed a five-year, $252 million maximum rookie-scale contract extension, with a player option in the fifth season, sources tell ESPN.
Proud of my graduating pharmacy residents- PGY1 and PGY2 ID residents at @UHPharmRes
Lindsey Groff, PharmD, BCIDP retweeted
TEXAS TAKES IT IN TWO 🔥
THE LONGHORNS ARE WOMEN'S COLLEGE WORLD SERIES CHAMPS ONCE AGAIN 🏆🤘
Grateful to have attended the MAD-ID SIDP meeting in Orlando, FL.
#IDPharmacy #GramNegativeResistance
If you know of any leads on ID pharmacist potions available in Texas, please send them my way. I have two strong ID PGY2 still hunting for their dream positions.
Thanks everyone!
Lindsey Groff, PharmD, BCIDP retweeted
We hope you are still considering Ohio State and joining an amazing ID pharmacist team (biased, I know 🙂). Just an update that our app deadline is now Friday, 4/10!
With the opening of the new University Hospital, we are so excited to share we are also recruiting for another inpatient ID pharmacy team member to join ASP, rounds, research, and teaching @OSUWexMed! Apply today!!! 🦠 #IDTwitter #TwitteRx careers.wexnermedical.osu.ed…
Lindsey Groff, PharmD, BCIDP retweeted
The number of referrals to ID doctors for latent tuberculosis has exploded. What happened? Read the latest from @PaulSaxMD: voices.nejm.org/doi/full/10.…
ALT Top: On the first visit, a trained health care provider places a TB skin test. Image Credit: Centers for Disease Control and Prevention Bottom: A trained health care provider reads a TB skin test between 48 and 72 hours after placement. Image credit: Centers for Disease Control and Prevention
Lindsey Groff, PharmD, BCIDP retweeted
🤔🤔🤔What do you think the most common ID phrases the new matched ID residents should expect to hear next year?
I'll start:
"Source control is always the answer"
"Nothing kills like a beta-lactam"
"Is it a true penicillin allergy?"
Please comment common ID phrases below!
Lindsey Groff, PharmD, BCIDP retweeted
How often does pharmacist expertise change ID management?
📊1,518 curbside questions to ID pharmacists
💊 38% about antimicrobial regimen optimization
⚖️ 27% about dosing
🧠Pharmacist input changed management in 89% of cases
ID Pharmacists = critical to the care team! #IDXPosts
Lindsey Groff, PharmD, BCIDP retweeted
Looking for that perfect job post-residency? Consider applying to be an OPAT pharmacist @OSUWexMed and join a team of seven other ID/HIV pharmacists! We can't wait to meet you! 🧫🦠 #IDTwitter #TwitteRx careers.wexnermedical.osu.ed…
Lindsey Groff, PharmD, BCIDP retweeted
Have you had to dose antimicrobials in patients with obesity?
The review article shared is my go to resource. Add it to your files to help with future drug dosing. 🧠🧠🧠
journals.asm.org/doi/10.1128…
Lindsey Groff, PharmD, BCIDP retweeted
Does this trial change your practice? Tell us in the comments below!
#Cdiff #POVancomycin 💩💩💩
🔥Just published 🔥
TAPER-V RCT
Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection
In this randomized clinical trial of 256, a 4-week vancomycin pulse and taper regimen *had a probability of 74% to be superior to astandard 2-week pulse regimen in patients a first episode or first recurrence of CDI
*All patients received 14d pulse of vanco (standardized at 125 mg orally 4 times a day at the time of recruitment) →taper (125 mg q12h ×7d,then 125mg q24h ×7d) vs placebo for management of CDI (first episode or recurrence).
Vanco for 10d is obsolete! #IDXposts
jamanetwork.com/journals/jam…
Lindsey Groff, PharmD, BCIDP retweeted
Does your site regularly complete therapeutic drug monitoring (TDM) of azole antifungals? Comment below the azole that you most often get TDM on. 💊💊🩸🩸
TDM inspiration:
academic.oup.com/jac/article…
46%Yes
54%No
87 votes • Final results Lindsey Groff, PharmD, BCIDP retweeted
HIV testing is based on the interplay of several virologic and immunologic events. Immediately after infection, the “eclipse period” begins, during which HIV replicates in local lymphoid tissue and is not detectable in the bloodstream by diagnostic tests. Learn more: nej.md/4ql7ehk
ALT A figure showing the viral and immune dynamics of HIV infection.
Lindsey Groff, PharmD, BCIDP retweeted
‼️Just shared at #IDWeek2025, our findings are now published in @OFIDJournal comparing cephalexin to cefdinir for uUTI in females. Spoiler: cefdinir was the only independent risk factor associated with/failure. Poor urinary PK = ⬆️failure. Let’s stop Rx’ing cefdinir for UTI! 🛑💊
🆕💫 Retrospective, multicenter cohort study(N: 367)
Cefdinir was independently associated with treatment failure with nearly twice as high of failure rate compared with cephalexin for the treatment of outpatient uncomplicated UTI #IDXposts #UTIWiki academic.oup.com/ofid/articl…
